跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEMAZYRE TABLETS 13.5 MG - HSA Drug Approval Details
Approvals
/
HSA
/
PEMAZYRE TABLETS 13.5 MG
Approved
THERAPEUTIC
PEMAZYRE TABLETS 13.5 MG
Lonza Tampa LLC
🇸🇬 Health Sciences Authority
Approval Date
Jul 9, 2024
Approval ID
5e95b8660a5a7e91
Company
Lonza Tampa LLC
Type
Therapeutic
Approval Details
Approval Id
5e95b8660a5a7e91
Drug Name
PEMAZYRE TABLETS 13.5 MG
Product Name
PEMAZYRE TABLETS 13.5 MG
Approval Number
SIN17044P
Approval Date
2024-07-09
Registrant
SPECIALISED THERAPEUTICS ASIA PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
L01EN02
Pharma Manufacturer Name
SPECIALISED THERAPEUTICS ASIA PTE. LTD.
Company Detail Path
/organization/specialised-therapeutics-asia-pte-ltd
Active Ingredients
Pemigatinib
13.50 mg
Pemigatinib
13.50 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 9, 2024
Approval ID
5e95b8660a5a7e91
Type
Therapeutic
Back to HSA Approvals